Approach grown

InterMune, Inc.
(Nasdaq: ITMN) announced results today from preclinical studies of
pirfenidone that identify a molecular butt of the compound’s
anti-fibrotic interest. Pirfenidone is the Company’s insignificant molecule drug
seeker that is being developed for the treatment of patients with
idiopathic pulmonary fibrosis (IPF) in its Phase III program, DIMENSIONS. The
in vitro studies present that pirfenidone suppresses fibrogenesis
through selective inhibition of the p38-gamma mitogen-activated protein
kinase (MAPK). The results will be included in a presentation made today by
InterMune scientists at GTCbio’s Protein Kinases in Drug Discovery and
Development Conference being held in Boston, Massachusetts.

In IPF, fibrosis occurs when wound healing cells deposit collagen,
which leads to peculiar scarring of the lung tissues. Previous inquiry
demonstrates that pirfenidone reduces blood plasma levels in vivo of
TGF-beta and Interleukin-4, two pro-fibrotic signaling molecules, and
significantly inhibits TGF-beta-induced collagen synthesis in vitro.
Pirfenidone was also shown to control production of TNF-alpha, a molecule
intricate with inflammation. In this late-model work, InterMune scientists have
shown a principal anti-fibrotic mechanism of action of pirfenidone as the
restraint of the p38- gamma kinase. In weather of this, InterMune studies
have demonstrated specificity of pirfenidone for the p38-gamma isoforms in
biochemical kinase assays as well as the attenuation of TGF-beta induced
collagen integrating following treatment of cells with pirfenidone. These new
studies demonstrate a link between inhibition of p38-gamma and a specific
marker of fibrogenesis.

“Extensive industry-wide analysis has demonstrated that the p38-alpha
isoform regulates numerous biological processes that participate an important duty
in inflammatory diseases. The anti-fibrotic mechanism of act of
pirfenidone involving selective barrier of p38-gamma and its associated
inhibition of collagen synthesis may test to be an important basics in
the treatment of fibrotic lung diseases. InterMune’s ongoing ROOM
trials are designed to ascertain if the anti-fibrotic activity of
pirfenidone purpose occur in weighty benefit for patients with IPF,” said
Lawrence M. Blatt, Ph.D., Chief Scientific Officer of InterMune.

Relative to IPF

IPF is a disabling and finally fatal disease that affects
close to 83,000 people in the United States, with approximately 30,000
remodelled cases developing each year. InterMune estimates there is a significant
IPF population in Europe. Those diagnosed with IPF are usually between the
ages of 40 and 70, and the infection tends to affect men more than women. IPF
causes inflammation and scarring (fibrosis) in the lungs, hindering a
person’s talent to convert oxygen and causing shortness of breath
(dyspnea) and cough. IPF is a progressive disease, meaning that over someday,
lung scarring and symptoms increase in severity. The disease is very
deadly, with a median survival time from diagnosis of two to five years,
and a five-year survival under any circumstances of around 20 percent. There are
currently no drugs approved by the U.S. Food and Drug Conduct (FDA)
and European Medicines Evaluation Force (EMEA) for the duration of the treatment of IPF.

Take InterMune

InterMune is a biotechnology company focused on the research,
development and commercialization of innovative therapies in pulmonology
and hepatology. InterMune has a pipeline portfolio addressing idiopathic
pulmonary fibrosis (IPF) and hepatitis C virus (HCV) infections. The
pulmonology portfolio includes two Phase III programs evaluating thinkable
therapeutic candidates for treatment of patients with IPF: the INSPIRE
trial is evaluating Actimmune(R) and the CAPACITY program is evaluating
pirfenidone. The hepatology portfolio includes the lead HCV protease
inhibitor compound, ITMN-191, formerly referred to as ITMN B, a
number two-formation HCV protease inhibitor program, and a probing program
evaluating a new end in hepatology. For additional word anent
InterMune and its R&D passage, please visit http://www.intermune.com/.

Except for the historical word contained herein, this swarm
let go contains predestined forward-looking statements that involve risks and
uncertainties, including without limitation the statements interrelated to the
progress, future patient enrollment in and timing of our clinical trials
and announcements of results thereof. All forward-looking statements and
other poop included in this the papers release are based on intelligence
readily obtainable to InterMune as of the date hereof, and InterMune assumes no
obligation to update any such forward-looking statements or message.
InterMune’s actual results could differ materially from those described in
InterMune’s forward- looking statements. Factors that could case or
contribute to such differences contain, but are not limited to, those
discussed in group specifically care of the heading “Risk Factors” in InterMune’s annual
report on Conformation 10-K filed with the SEC on March 13, 2006 (the “Form 10-K”)
and other periodic reports filed with the SEC, including the following: (i)
risks related to the development of our product and product candidates;
(ii) risks related to opportune patient enrollment and retention in clinical
trials, including the use of third parties to conduct such clinical trials;
(iii) risks related to achieving complimentary clinical trial results; (iv)
risks related to our mastermind property rights; and (v) risks related to
the haphazard, prolix and up-market clinical development and regulatory
process, including having no unexpected safety, toxicology, clinical or
other issues. The risks and other factors discussed first of all should be
considered but in connection with the fully discussed risks and other
factors discussed in detail in the Form 10-K and InterMune’s other episodic
reports filed with the SEC.

InterMune, Inc.
http://www.intermune.com/

Dream up an epidural or a control things of Novocain that doesn’t paralyze your legs or make you numb, yet totally blocks your labour.

This type of pain management is now within reach. As a result, childbirth, surgery and trips to the dentist might be less traumatic in the future, thanks to researchers at Massachusetts General Hospital (MGH) and Harvard Medical School, who have succeeded in selectively blocking pain-sensing neurons in rats without interfering with other types of neurons.

The pint-sized subjects received injections near their sciatic nerves, which run down their hind limbs, and subsequently lost the ability to feel pain in their paws. But they continued to move normally and react to touch. The injections contained QX-314, a normally inactive derivative of the local anesthetic lidocaine, and capsaicin, the active ingredient in hot peppers. In combination, these chemicals targeted only pain-sensing neurons, preventing them from sending signals to the brain.

“We’ve introduced a local anesthetic selectively into specific populations of neurons,â€? explains Harvard Medical School Professor Bruce Bean, an author on the paper, which appears in Nature on Oct. 4. “Now we can block the activity of pain-sensing neurons without disrupting other kinds of neurons that control movements or non-painful sensations.â€?

“We’re optimistic that this method will eventually be applied to humans and change our experience during procedures ranging from knee surgery to tooth extractions,â€? adds Professor Clifford Woolf of Massachusetts General Hospital, who is senior author on the study.

Despite enormous investments by industry, surgical pain management has changed little since the first successful demonstration of ether general anesthesia at MGH in 1846. General and local anesthetics work by interfering with the excitability of all neurons, not just pain-sensing ones. Thus, these drugs produce dramatic side effects, such as loss of consciousness in the case of general anesthetics or temporary paralysis for local anesthetics.

comprar viagra madrid

“We’re offering a targeted approach to pain management that avoids these problems,â€? says Woolf.

The new work builds on research done since the 1970’s showing how electrical signaling in the nervous system depends on the properties of ion channels, that is, proteins that make pores in the membranes of neurons.

“This project is a perfect illustration of how research trying to understand very basic biological principles can have practical applications,� says Bean.

The new method exploits a membrane-spanning protein called TRPV1, which is unique to pain-sensing neurons. TRPV1 forms a large channel, where molecules can enter and exit the cell. But a “gate� typically blocks this opening. The gate opens when cells are exposed to heat or the chili-pepper ingredient capsaicin. Thus, bathing pain-sensing neurons in capsaicin leaves these channels open, but non-pain sensing neurons are unaffected because they do not possess TRPV1.

The new method then takes advantage of a special property of the lidocaine derivative QX-314. Unlike most local anesthetics, QX-314 can’t penetrate cell membranes to block the excitability of the cell, so it typically lingers outside neurons where it can’t affect them. For this reason it is not used clinically.

When pain-sensing neurons are exposed to capsaicin, however, and the gates guarding the TRPV1 channels disappear, QX-314 can enter the cells and shut them down. But the drug remains outside other types of neurons that do not contain these channels. As a result, these cells fully retain their ability to send and receive signals.

The team first tested their method in the Petri dish. Alexander Binshtok, a postdoctoral researcher in Woolf’s lab, applied capsaicin and QX-314 (separately and in combination) to isolated pain-sensing and other neurons and measured their responses. Indeed, the combination of capsaicin and QX-314 selectively blocked the excitability of pain-sensing neurons, leaving the others unaffected.

Next, Binshtok injected these chemicals into the paws of rats and measured their ability to sense pain by placing them on an uncomfortable heat source. The critters tolerated much more heat than usual. He then injected the chemicals near the sciatic nerve of the animals and pricked their paws with stiff nylon probes. The animals ignored the provocation. Although the rats seemed immune to pain, they continued to move normally and respond to other stimuli, indicating that QX-314 failed to penetrate their motor neurons.

The team must overcome several hurdles before this method can be applied to humans. They must figure out how to open the TRPV1 channels without producing even a transient burning pain before QX-314 enters and blocks the neurons, and they must tinker with the formulation to prolong the effects of the drugs. Both Bean and Woolf are confident they’ll succeed.

“Eventually this method could completely transform surgical and post-surgical analgesia, allowing patients to remain fully alert without experiencing pain or paralysis,� says Woolf. “In fact, the possibilities seem endless. I could even imagine using this method to treat itch, as itch-sensitive neurons fall into the same group as pain-sensing ones.�

http://www.hms.harvard.edu/

A University of Michigan expert on menopause says a recent memorize that indicates placebos work as wonderfully as antidepressant drugs to help hot flashes shows how much more research is needed with reference to what gives patients recess.

Nancy Reame, a U-M nursing scientist, was invited by the journal Menopause to evaluate a new study published in today’s issue. The study was conducted in Finland, led by Dr. Eila Suvanto-Luukkonen. Reame’s editorial, called “The emerging science of hot flash relief: Legitimizing the ‘obecalp’ effect,” is in the same issue. “Obecalp” is placebo spelled backwards.

“These pharmaceutical drugs did work. There was significant improvement in 60 to 70 percent of women who took two popular classes of antidepressants. The problem was the placebo also had the same effect,” said Reame, the Rhetaugh Graves Dumas Professor of Nursing at U-M.

Suvanto-Luukkonen conducted a nine-month study of selective serotonin reuptake inhibitor (SSRI) antidepressants—the first study longer than 12 weeks—that showed little difference between placebos and antidepressants for hot flashes.

“We don’t pay much attention in a scientific way to why a placebo works,” said Reame, also a research scientist with the U-M Reproductive Sciences Program.

Reame suggested it is possible women suffering hot flashes respond to health care professionals who create a caring environment and manage symptoms in a holistic way in collaboration with the patient. If that is the case, she says, the drug itself might be less important than the total package given by a doctor or nurse.

impotencia sexual masculina

“There is a sense that a placebo is a bad thing,” she said. “I want to turn that around and think of it as self healing.

“We need to appreciate the value of providing a therapeutic environment where the patient gets benefits out of the whole health care interaction, apart from any drug effect,” Reame said.

Self-healing involves a whole range of activities that reduce anxiety and harness the patient’s ability to promote her own wellness. In the case of menopausal women, it means taking control of your own symptoms by getting good education from health care provider, using daily diaries to track hot flashes, monitoring them when they are most bothersome, reflecting on their severity and taking a systematic inventory of behavior in relation to the hot flashes.

All of this happens as part of a scientific study like the one on SSRIs. The process prompts the women to pay careful attention to their experiences with interested people helping them track their data while they are also taking pills that they believe might be working, Reame noted.

Reame said understanding all treatment effects, not just prescription drug impact, is particularly needed in a time when women are worried about potential health risks associated with hormone replacement therapy, a popular way of addressing menopause.

For example, she said, a number of studies show that deep breathing is effective in quelling hot flashes. Similarly, a number of studies on pain show biochemical responses to self-healing—what this study calls the placebo.

To better understand one more holistic approach to menopause treatment, Reame is beginning a small-scale trial of the commonly used herbal supplement black cohosh for hot flashes.

Using a small grant from U-M for the pilot study, Reame and her neuroscience collaborators from the U-M School of Medicine will look at the effects of black cohosh on the brain and on hormone levels. Previous studies have done the same for estrogen therapy, so Reame’s team will look for similarities between black cohosh and estrogen’s effects in women’s bodies.

Reame said she sees two main possibilities for the strong anecdotal evidence that women get relief from black cohosh:

Black cohosh is working as an estrogen stimulator, generating a similar physical response to taking estrogen supplements.

Black cohosh triggers the placebo response, reducing hot flashes through something other than an estrogen biochemical route.

Reame will look at chemical receptors in the part of the brain that responds to opiate drugs. In pain studies, these chemicals are often stimulated by placebos in those subjects who get relief from placebos, she said, indicating it is not simply “all in your head” but a physical response just as powerful as that generated by pharmaceuticals.

http://www.umich.edu

The Crib Dynamism and Traffic Board on Wednesday by voice bear witness approved a bill (HR 1343) that would reauthorize the federal community health centers program through financial year 2012, CQ Today reports (Mattingly [1], CQ Today, 5/7).

cialis

The legislation, sponsored by Rep. Gene Green (R-Texas), would authorize more than $14 billion over five years in all 50 states; Washington, D.C.; and U.S. territories. The bill would provide $2.1 billion in FY 2008 and $2.5 billion in FY 2009.

In addition, the legislation would allow limited liability protection for physicians who volunteer at community health centers and extend liability protections to employees who travel to provide emergency care. The bill also would require 30 demonstration grants for integrated health systems that provide access to primary and preventive care (Posner, CongressDaily, 5/8).

Green said, “Health centers represent our nation’s largest primary health care system and serve as a medical home to more than 15 million Americans, the overwhelming majority of whom are low-income or uninsured individuals,” adding, “This bill will double the number of Americans who can be served in these health centers.” The Senate Health, Education, Labor and Pensions Committee in November 2007 approved a similar bill (S 901) (CQ Today, 5/7).

This article is republished with kind leave from our friends at The Kaiser Derivation Foundation. You can consider the entire Kaiser Daily Health Policy Probe, search the archives, or warning up for email delivery of in-depth coverage of health scheme developments, debates and discussions. The Kaiser Routine Health Policy Report is published looking for Kaisernetwork.org, a free service of The Henry J. Kaiser House Foundation. Copyright 2007 Advisory Board Company and Kaiser Family Organization. All rights sedate.

A new assault of experiments in mice confirms that a discernment receptor associated with the reinforcing effects of marijuana also helps to galvanize the advantageous and pleasurable effects of alcohol. The research, which was conducted at the U.S. Section of Energy’s Brookhaven Inhabitant Laboratory and was published online September 2, 2005, by the newsletter Behavioural Genius Research, confirms a genetic basis for susceptibility to alcohol berating and also suggests that drugs designed to hinder these receptors could be useful in treatment.

“These findings build on our understanding of how a variety of receptors in the brain’s honour circuits contribute to alcohol abuse, help us understand the role of genetic susceptibility, and move us farther along the path toward flourishing treatments,” said Brookhaven’s Panayotis (Peter) Thanos, possibility author of this study and diverse others on “reward” receptors and drinking (see: bnl.gov/bnlweb/pubaf/pr/PR_display.asp and , bnl.gov/thanoslab).

Earlier studies in animals and humans have suggested that so-called cannabinoid receptors known as CB1 — which are as soon as involved in triggering the reinforcing properties of marijuana — might also stimulate remunerate pathways in response to drinking hard stuff. Thanos’ troop investigated this syndicate in two experiments.

In the first experiment, they measured the bottle preference and intake in mice with different levels of CB1 receptors: preposterous strain mice with normal levels of CB1; heterozygous mice with approximately 50 percent levels; and so-called knockout (KO) mice that be the gene for CB1 and therefore take no CB1 receptors. All mice were given a exceptional of two drinking bottles, one with pure splash and one with a 10 percent alcohol revelation — approximately close to the alcohol satisfied of wine. Mice with the customary levels of CB1 receptors had a stronger preference fit hooch and drank more than the other two groups, with the CB1-sketchy mice showing the lowest alcohol consumption.

cialis

After establishing each group’s up to date on of drinking, the scientists treated animals with a drug known to close off CB1 receptors (SR141716A) and tested them again. (These animals were also compared with animals injected with plain saline to oversight someone is concerned the effect of the injection.) In response to the CB1 receptor-blocking drug, mice with conventional and transitional levels of receptors drank significantly less alcohol compared to their pre-treatment levels, while KO mice showed no alteration in drinking in retort to the treatment.

In the second proof, the scientists compared the tendency of mad classification and KO mice to seek not at home an mise en scene in which they had previously been premised alcohol. Known as “conditioned place preference,” this is an established genius for determining an animal’s preference for the duration of a drug.

Animals were first conditioned to “expect” alcohol in a addicted portion of a three-chambered enclose while being given an injection of saline in the opposite end, and then monitored for how much time after time they weary in the alcohol body “seeking” the drug. Enthusiastic group animals, with normal levels of CB1, spent more time in the alcohol-associated chamber than the saline compartment, showing a unequivocal preference, while KO mice (with no CB1 receptors) showed no significant preference for song chamber over the other.

“These results underpinning our belief that the cannabinoid way and CB1 receptors play a censorious role in mediating the advantageous and pleasurable properties of alcohol, contributing to alcohol dependency and abuse,” Thanos said.

In uniting, the reality that the mice with intermediate levels of CB1 exhibited alcohol bent and intake midway between those with penetrating levels of receptors and those with none suggests that the genetic distinction between strains quantitatively influences the inclination owing and the amount of alcohol consumed. “These results equip further evince an eye to a genetic component to alcohol misemploy that includes the CB1 gene — the uniform gene that is urgent for the behavioral effects of marijuana,” Thanos said.

While it remains unclear expressly how CB1 triggers the rewarding effects of alcohol, one possibility is that activation of the CB1 receptor somehow blocks the brain’s normal “stop” signals for the production of dopamine, another brain chemical known to have fun a post in addiction. Without the stop signal, more dopamine is released to bring forward a pleasure/reward comeback.

Since blockade of the CB1 receptor with SR141716A appears to effectively reduce rot-gut intake and preference, this study also suggests that such CB1 receptor-blocking drugs muscle depict an important rele in the prospective treatment of alcohol abuse.

This study was funded by the Office of Biological and Environmental Research within the U.S. Be subject to of Energy’s (DOE) Organization of Science; by the National Institute on Drug Abuse and the Intramural Research Program of the NIH, [National Guild on The cup that cheers Abuse and Alcoholism]. The DOE has a prolonged-standing interest in examination on addiction that builds, as this swotting does, on the insight of intellect receptors gained fully brain-imaging studies. Brain-imaging techniques such as MRI and SNUGGLE are a direct outgrowth of DOE’s support of key physics research.

Note to local editors: Peter Thanos lives in Coram, Further York.

One of ten public laboratories overseen and primarily funded by the Office of Expertise of the U.S. Be influenced of Stick-to-it-iveness (DOE), Brookhaven Public Laboratory conducts probe in the specialist, biomedical, and environmental sciences, as well as in energy technologies and national safeguarding. Brookhaven Lab also builds and operates major scientific facilities available to university, industry and government researchers. Brookhaven is operated and managed for DOE’s Office of Science by Brookhaven Science Associates, a limited-responsibility company founded by Stony Brook University, the largest academic alcohol of Laboratory facilities, and Battelle, a nonprofit, applied science and technology body.

Karen McNulty Walsh
kmcnulty@bnl.gov
631-344-8350
DOE/Brookhaven National Laboratory
http://www.bnl.gov

Thousands of Americans agony from the confirmed inflammatory bowel condition known as Crohn’s disease are leading longer, healthier lives due to innovative new surgeries, according to experts at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.

Comprar viagra

“Four old-fashioned of five Crohn’s patients will require some kind of surgery at some point during their lives, but these advanced, often minimally invasive techniques are stingy valuable bowel chain while improving superiority of brio,” says senior author Dr. Fabrizio Michelassi, Lewis Atterbury Stimson Professor and chairman of the Department of Surgery at Weill Cornell Medical College and surgeon-in-chief at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.

He and co-author Dr. Sharon L. Stein, assistant professor of surgery at Weill Cornell Medical College and colorectal surgeon at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, wrote a “state of the science” evaluate in a recent oppose of the minutes Serviceable Gastroenterology.

As numberless as 500,000 people in the U.S. suffer from Crohn’s disease, which triggers infection along the gastrointestinal lot, most typically in the disgrace bowel. Inexorable drugs can advise simplify symptoms, but there is no cure destined for this continuing illness. Some of the more rigid complications of Crohn’s disease encompass strictures (narrowing of the bowel), abscesses, perforations, fistulas (abnormal, obstructive connections between tissues), hemorrhage and even cancers. These types of complications often order surgical intervention.

“In the past, this was restricted to complex, invasive surgeries that required the dethronement of with few exceptions sections of the affected bowel. But over the past two decades, advances in surgery have changed that paradigm,” Dr. Stein notes.

Some of the innovations outlined in the comment on embody:

* Laparoscopic Surgery. “Patients — especially younger patients — prefer laparoscopic surgery because the small incision intricate leaves bantam extrinsic scarring, settle accounts after repeat procedures,” Dr. Michelassi notes. These minimally invasive techniques also incline to fewer surgery-linked internal tissue adhesions. Laparoscopic procedures do tend to coerce more training on the to some extent of surgeons, and they can scram longer to conduct than regular surgery. “However, they also lead to shorter hospital stays, qualifying money and getting patients home faster,” Dr. Stein notes.

* Strictureplasty. This technique has revolutionized bowel surgery, the experts say. “In the past, surgeons would upset out whole sections of diseased bowel, shortening the organ and thereby limiting gastrointestinal function,” explains Dr. Michelassi, a world-celebrated pioneer in the technique. With strictureplasty, surgeons leave the bogus length of bowel in place but widen it, “much like letting out the seams on a pant-leg,” he says. This spares bowel fabric while “restructuring” it, so that intestinal contents can safely pass completely.

* Fistula Plugs. Fistulas can be both painful and dangerous, causing intestinal contents to diverge from the anal canal. This often leads to anal incontinence, abscesses and, most seriously, systemic infection. Certain surgeries can drain the fistula tract but concerning more finical lesions a new surgical anal plug — made from grafted porcine series — is placed during the fistula. The plug triggers the growth of close by fibrotic mass that then closes potty the fistula area. “In studies, this approach has proven successful in up to half of Crohn’s patients,” Dr. Stein says.

These and other surgical advances are giving patients valuable new options against a relentless disease, Dr. Michelassi says.

“In our manoeuvre here at NewYork-Presbyterian/Weill Cornell, we’re learning that we can do so much more than we kindliness we could — reducing surgical risks, sparing bowel and help patients prepare better outcomes,” he says.

Dr. Stein agrees. “As we learn more, and grow more relaxing with these techniques, our success emboldens us to reach in search the next genesis of advances. Year by year, it’s making a real difference in patients’ lives.”

The study, “New Advances in Surgical Treatment of Crohn’s Disease,” can be create in the April 2008 issue of Sound Gastroenterology.

NewYork-Presbyterian Hospital/Weill Cornell Medical Center

NewYork-Presbyterian Hospital/Weill Cornell Medical Center, located in New York City, is one of the outstanding theoretical medical centers in the in seventh heaven, comprising the teaching hospital NewYork-Presbyterian and Weill Cornell Medical College, the medical school of Cornell University. NewYork-Presbyterian/Weill Cornell provides report-of-the-art inpatient, ambulatory and preventive sadness in all areas of medicine, and is committed to excellence in patient care, education, scrutinization and community service. Weill Cornell physician-scientists have been responsible for many medical advances — from the enlargement of the Pap test for cervical cancer to the mixing of penicillin, the first lucky embryo-biopsy pregnancy and ancestry in the U.S., the initial clinical trial for gene therapy for Parkinson’s disease, the first indication of bone marrow’s ticklish job in tumor growth, and, most recently, the world’s key successful use of Davy Jones’s locker brain stimulation to deal with a minimally wilful brain-injured diligent. NewYork-Presbyterian, which is ranked sixth on the U.S.News & Magic Report heel of top hospitals, also comprises NewYork-Presbyterian Hospital/Columbia University Medical Center, Morgan Stanley Children’s Hospital of NewYork-Presbyterian, NewYork-Presbyterian Hospital/Westchester Part and NewYork-Presbyterian Hospital/The Allen Pavilion. Weill Cornell Medical College is the first U.S. medical college to proposition a medical degree overseas and maintains a dazzling global presence in Austria, Brazil, Haiti, Tanzania, Turkey and Qatar.

NewYork-Presbyterian Convalescent home
Weill Cornell Medical Center

The HIV/AIDS league BAHA has formed a partnership with more than 90 hotels and guest houses in Papua Budding Guinea to attend to arrange for about two million no-cost condoms to guests, ABC Online reports. Eileen Seneve of BAHA said that the organization targeted hotels inasmuch as the condom distribution race because many people are exposed to the virus at the establishments. “It’s there, it’s available, so hopefully they’ll partake of it,” she said, adding that the group also transfer provide training to inn help. The condoms will be packaged in wrappers designed by municipal artists, following comments from a hotel chain that the original packaging was too bland, according to ABC Online (Fox, ABC Online, 3/20).

Reprinted with amiable permission from http://www.kaisernetwork.org. You can vista the entire Kaiser Daily Health Practice Report, search the archives, or sign up for email childbirth at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Continuously Robustness Procedure Report is published as kaisernetwork.org, a free appointment of The Henry J. Kaiser Division Inauguration.

impotencia masculina

© 2009 Advisory Game table Convention and Kaiser Set Foundation. All rights reserved.

Major clinical investigation has start that for many patients with clogged arteries, route surgery is a better choice than anaesthetize-eluting stents.

The Dutch researchers say for patients with difficult-to-treat clogged arteries, surgery was best, as those given a drug-coated stent were more likely to need a repeat procedure.

Patients typically need at least a month to fully recover from open-heart surgery which can be a five-hour long operation under general anesthesia, whereas angioplasty patients are often up and walking around after three days.

The results of the ‘SYNTAX’ study comparing Boston Scientific’s drug-coated Taxus stents with bypass surgery have been eagerly awaited.

The researchers found after a 12 month study of more than 3,000 patients in Europe and the United States, that 17.8 percent of patients receiving stents either died, suffered a heart attack, had a stroke or needed a repeat procedure.

The figure was 12.1 percent for those undergoing surgery and receiving coronary artery bypass grafting, known as CABG.

The study excluded patients who had acute heart attacks and included those who had single and multiple vessel blockages.

Stents are tiny wire-mesh tubes used to prop open clogged heart arteries and were first introduced in the 1990s and the procedure, which allows doctors to treat patients by inserting a catheter into the groin, means a very quick recovery time, whereas CABG requires open-heart surgery.

Comprar viagra espana

Research in 2006 revealed that patients with the drug-coated stents were more likely to develop potentially fatal blood clots months and even years after they were implanted and in January this year more research found that bypass surgery was still the best option for heart patients with more than one clogged artery.

Some experts say the results might not lead to a dramatic change in practice since many of the patients in the Dutch study would probably have received surgery anyway in normal clinical practice.

But a more favorable result for stenting could have encouraged further use of stenting over CABG; Boston Scientific say the study was reassuring for the use of stents, despite not achieving its goal.

Experts warn that more data is still needed about the pros and cons of bypass surgery versus angioplasties, and that patients need to be tracked for at least five years.

The researchers presented the findings at the annual meeting of the European Society of Cardiology where Douglas Weaver, President of the American College of Cardiology, commented that surgery has ‘come out a winner’.

The study was funded by Boston Scientific.

Scientists are reporting the strongest evidence to date that neurodegenerative diseases end and headway along different neural networks that normally support nourishing planner assignment.

The discovery could lead to earlier diagnoses, novel treatment-monitoring strategies, and, possibly, recognition of a common disease process among all forms of neurodegeneration.

The study, reported in the April 16 issue of the journal ” Neuron, ” was conducted by scientists at the University of California, San Francisco and the Stanford University School of Medicine, who characterized their finding as “an important new framework for understanding neurodegenerative disease.”

The finding inspired the image for the cover of the issue of the journal.

Researchers have known that neurodegenerative diseases are associated with misfolded proteins that aggregate within specific populations of neurons in the brain. Alzheimer’s disease, for instance, results from misfolding events involving beta-amyloid and tau proteins, which result in neuritic plaque and neurofibrillary tangle formation in medial temporal memory structures. In all neurodegenerative diseases, synapses between nerve cells falter, and damage spreads to new regions, accompanied by worsening clinical deficits.

In most cases, however, scientists have not known what determines the specific brain regions affected by a disease. The current neuroimaging study, which examined patients with five forms of early age-of-onset dementia — Alzheimer’s disease, behavioral variant frontotemporal dementia, semantic dementia, progressive nonfluent aphasia, and corticobasal syndrome – as well as two groups of healthy controls, showed that each disease targets a different neural network.

“The study suggests that these diseases don’t spread across the brain like a wave but instead travel along established neural network pathways,” says the lead author of the study, William W. Seeley, MD, assistant professor of neurology at the UCSF Memory and Aging Center.

Earlier work performed by Michael Greicius, MD, senior author and assistant professor of neurology and neurological sciences at Stanford, provided Seeley with the inspiration for the present study, which extended Greicius’ work on Alzheimer’s disease to a host of additional dementias. The findings suggest that network degeneration represents a class-wide neurodegenerative disease phenomenon.

“Something about a network’s architecture or biology is either bringing the disease to networked regions or propagating disease between network nodes,” says Seeley.

At this point, the scientists have shown that the diseases cause atrophy in networked regions. “We still need to determine how the diseases impact connectivity, and we don’t yet know how, at the molecular level, disease spreads between networked areas,” says Seeley.

Greicius further commented, “These results suggest that brain imaging measures of network strength should be sensitive enough to detect these diseases at an early stage and, as importantly, specific enough to reliably distinguish one disease from the others.”

If all forms of neurodegenerative disease are propagated along synaptic connections, says Seeley, “the framework would have major mechanistic significance, predicting that the spatial patterning of disease relates to some structural, metabolic or physiological aspect of neural network biology.”

“We hope our finding will stimulate basic researchers to try to understand the molecular mechanisms for network-based neurodegeneration,” he says.

comprar viagra espana

Meanwhile, Seeley, Greicius, and their colleagues plan to test neural network-based diagnostic and disease-monitoring studies in younger people with genetic predispositions to Alzheimer’s disease and frontotemporal dementia. The goal is to try to track incipient changes in neural network connectivity and, ultimately, to track how well new experimental drugs can repair or maintain connectivity once an individual begins to show signs of dysfunction.

“Our hope is to develop tools that can detect these diseases even before symptoms emerge, so that disease-modifying therapies can get started before it is too late,” Seeley concludes.

http://www.ucsf.edu/

Monetary gain is far from being the only motivation after violent byway someone’s cup of tea robbery in the UK. It is often carried absent from because of a sheer desire to fight, to gain d stage legal perceived one-sidedness, to heighten “street cred” or level even-handed for “kicks.” This emerges from a redone learn about funded by the Economic and Social Research Directory (ESRC).

Both the amount and the rigour of gratuitous damage used in street pillage are increasing in the UK, but because the tally of studies is very wee and tends to be little to what the exact post was in each case and whether the assault was likely to lead to financial gain, this worrying social unmanageable is poorly documented and understood.

impotencia masculina

At this very moment, however, Professor Trevor Bennett, Top banana of the Centre as a service to Criminology, University of Glamorgan and Dr. Fiona Brookman have provided dramatic insights into the duty of street elegance in the motivation and enactment of ferocious street felony. They interviewed 120 offenders, generally maturity 26, of whom one third said they had been arrested 50 times or more. Overall, 92 per cent had used unauthorized drugs. Single third said they were involved in gangs or criminal groups. Over a quarter carried firearms and an additional 35 per cent carried some other weapon, most of the time a cut.

One offender describes how he spent the money from a recent nicking on good times and partying, buying and using drugs. “I went back to my edifice to obstacle things dispassionate down before I went ruin to the bar. Partied the in money away and the next heyday I got arrested.”

A two shakes of a lamb’s tail base intent is to use the proceeds from robbery to believe non-essential, status-enhancing items. As one offender reported, owning a certain epitome of car and cruising slowly in residential areas with the sound structure turned up loud was a method of marking their alertness and obtaining status on the streets. ” after we done a some armed robberies I bought a type fresh car . It’s like showing mistaken, really.”

Again, hijack is initiate by some to be a pleasurable work in its own right. One offender said he was addicted to it. “It weren’t down repay after money. It was nothing but - I had money; it was more peer the call up you get from doing things. I was more addicted to robbing than I was to drugs. Just get a funny feeling when I go out robbing.” One element in the ebullience came from overpowering the victim and obtaining dominance.

“It’s through despite the fun - ‘Cos the inapt of street robbery is to enjoy them to withstand back, innit” I’d present him a unite of slaps and recite say him to fight back, yeah. If he won’t fight raw, we just give him a kick and go.”

Robberies can also be prompted by anger and the desire to start a fight, with cash being taken only as an afterthought. Here the unfluctuating of violence used is often beyond that required to secure the victim’s compliance. “I picked a make with someone on the street. They were the blue ribbon people I come across. I started hitting joke of them and metier him names and said, ‘What are you looking at”‘ and clobber like that. Then I can’t remember how but I started hitting him and then I lawful jumped on him. Punched him, turned him over, went by way of his pockets.”

Finally, some robberies were committed as a approachable of informal justice in which the offender felt he or she had righted some deteriorate done to them.

Overall, some kind of drugs connection was mentioned in 60 per cent of all robberies reported.

“I was walking down the high road and I byword this boy and bit of skirt walking along, like. I grabbed her handbag and grabbed his phone open him and run off. I was desperate for crevice.”

The examine database gives ample leeway seeing that further judgement. Meanwhile, Professor Bennett says, “The decision to transfer street robbery can be explained in part by exact characteristics of the circle enlightenment. This finding is grave because British research has tended to explain thieving in terms of rational choice and to focus instead on the role of cost-honour calculations. Our analyse suggests that any explanation must primarily treat into account cultural factors associated with life on the street.”

—————————-
Article adapted by Medical Communication Today from prototypical Fleet Street release.
—————————-

1. The research project “A qualitative study of the role of barbarity in concourse crime” was funded by the Economic and Social Research Council (ESRC). Professor Trevor Bennett is Chief honcho of the Focus for Criminology, Clique of Law, Humanities and Social Sciences, University of Glamorgan, Pontypridd, CF37 1DL.

2. Methodology: Semi-structured interviews were conducted with 120 offenders (89 males, 31 females, 10per cent disastrous, 12 per cent mixed race) serving sentences for ruinous offences in prisons and young offenders’ institutions in England and Wales.

3. The ESRC is the UK’s largest funding operation for examination and postgraduate training relating to sexually transmitted and economic issues. It provides independent, exhilarated standing, relative delve into to business, the flagrant sector and Government. The ESRC’s planned total expenditure in 2006-07 is 169 million pounds. At any one space the ESRC supports finished 4,000 researchers and postgraduate students in visionary institutions and examination policy institutes.

4. ESRC Union Today offers accessible access to a broad range of community science analysis and presents it in a respect that makes it peaceful to navigate and saves users valuable time. As entirely as bringing together all ESRC-funded research (formerly accessible via the Regard website) and key online resources such as the Social Science Information Gateway and the UK Facts Archive, non-ESRC resources are included, for example the Office for National Statistics. The portal provides access to advanced findings and research summaries, as thoroughly cooked as full texts and primeval datasets through integrated search facilities.

5. The ESRC confirms the status of its funded research by evaluating research projects through a process of marchioness review. This research has been graded as ‘good’.

Contact: Annika Howard

Economic & Social Research Council